COMPLETE TEST BANK FOR PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRACTICAL APPROACH FIFTH, NORTH AMERICAN EDITION BY VIRGINIA POOLE ARCANGELO ISBN 978-1975160593 LATEST UPDATE !!2024/2025|VERIFIED ANSWERS!!!!

TestVBankVForVPharmacotherapeuticsVForVAdvancedVPracticeVAV
PracticalVApproachV5thVEdition

, lOM V oARcV PSD|V301
3804




V oARcV PSD|V3013804
lOM




Chapter 1 Issues for the Practitioner in Drug Therapy
V V V V V V V V




MULTIPLE CHOICE V




1. Nurse practitioner prescriptive authority is regulated by:
V V V V V V




A. The National Council of State Boards of Nursing
V V V V V V V




B. The U.S. Drug Enforcement Administration
V V V V




C. The State Board of Nursing for each state
V V V V V V V




D. The State Board of Pharmacy
V V V V




ANS: C V PTS: 1 V




2. Physician Assistant (PA) prescriptive authority is regulated by:
V V V V V V V




A. The National Council of State Boards of Nursing
V V V V V V V




B. The U.S. Drug Enforcement Administration
V V V V




C. The State Board of Nursing
V V V V




D. The State Board of Medical Examiners
V V V V V




ANS: D V PTS: 1 V




3. Clinical judgment in prescribing includes:
V V V V




A. Factoring in the cost to the patient of the medication prescribed
V V V V V V V V V V




B. Always prescribing the newest medication available for the disease process
V V V V V V V V V




C. Handing out drug samples to poor patientsV V V V V V




D. Prescribing all generic medications to cut costs V V V V V V




ANS: A V PTS: 1 V




4. Criteria for choosing an effective drug for a disorder include:
V V V V V V V V V




A. Asking the patient what drug they think would work best for them
V V V V V V V V V V V




B. Consulting nationally recognized guidelines for disease management
V V V V V V




C. Prescribing medications that are available as samples before writing a prescription
V V V V V V V V V V




D. Following U.S. Drug Enforcement Administration (DEA) guidelines for pres
V V V V V V V V




cribing
ANS: B V PTS: 1 V




5. Nurse practitioner practice may thrive under health-care reform due to:
V V V V V V V V V




A. The demonstrated ability of nurse practitioners to control costs and improve patient outco
V V V V V V V V V V V V




mes
B. The fact that nurse practitioners will be able to practice independently
V V V V V V V V V V




C. The fact that nurse practitioners will have full reimbursement under health-
V V V V V V V V V V




care reform V




D. The ability to shift accountability for Medicaid to the state level
V V V V V V V V V V




ANS: A V PTS: 1 V

, lOM V oARcV PSD|V301
3804




Chapter 2.Pharmacokinetic Basis of Therapeutics and Pharmacodynamic
V V V V V V




MULTIPLE CHOICE V




1. A patient’s nutritional intake and lab work reflects hypoalbuminemia. This is critical to presc
V V V V V V V V V V V V V




ribing because: V




A. Distribution of drugs to target tissue may be affected V V V V V V V V




B. The solubility of the drug will not match the site of absorption
V V V V V V V V V V V




C. There will be less free drug available to generate an effect
V V V V V V V V V V




D. Drugs bound to albumin are readily excreted by the kidney
V V V V V V V V V




ANS: A V PTS: 1 V




2. Drugs that have a significant first-pass effect:
V V V V V V




A. Must be given by the enteral (oral) route only
V V V V V V V V




B. Bypass the hepatic circulation V V V




C. Are rapidly metabolized by the liver and may have little if any desired action
V V V V V V V V V V V V V




D. Are converted by the liver to more active and fat-soluble forms
V V V V V V V V V V




ANS: C V PTS: 1 V




3. The route of excretion of a volatile drug will likely be:
V V V V V V V V V V




A. The kidneys V




B. The lungs V




C. The bile and feces V V V




D. The skin V




ANS: B V PTS: 1 V




4. Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage reservoir of the drug. V V V V V V V V V V V V V




Storage reservoirs:
V V




A. Assure that the drug will reach its intended target tissue
V V V V V V V V V




B. Are the reason for giving loading doses
V V V V V V




C. Increase the length of time a drug is available and active
V V V V V V V V V V




D. Are most common in collagen tissues
V V V V V




ANS: C V PTS: 1 V




5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
V V V V V V V V V V V V V V




A. Propensity to go to the target receptor V V V V V V




B. Biological half-life V




C. Pharmacodynamics
D. Safety and side effects V V V




ANS: B V PTS: 1 V




6. Azithromycin dosing requires the first day’s dose be twice those of the other 4 days of the prescri
V V V V V V V V V V V V V V V V V




ption. This is considered a loading dose. A loading dose:
V V V V V V V V V




A. Rapidly achieves drug levels in the therapeutic rangeV V V V V V V




B. Requires four to five half-lives to attain V V V V V V




C. Is influenced by renal function
V V V V

, lOM V oARcV PSD|V301
3804




D. Is directly related to the drug circulating to the target tissues
V V V V V V V V V V




ANS: A V PTS: 1 V V




7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect i
V V V V V V V V V V V V V V V V V V




s the:
V




A. Minimum adverse effect level V V V




B. Peak of action V V




C. Onset of action V V




D. Therapeutic range V




ANS: C V PTS: 1 V




8. Phenytoin requires a trough level be drawn. Peak and trough levels are done:
V V V V V V V V V V V V




A. When the drug has a wide therapeutic range
V V V V V V V




B. When the drug will be administered for a short time only
V V V V V V V V V V




C. When there is a high correlation between the dose and saturation of receptor sites
V V V V V V V V V V V V V




D. To determine if a drug is in the therapeutic range
V V V V V V V V V




ANS: D V PTS: 1 V




9. A laboratory result indicates the peak level for a drug is above the minimum toxic conce
V V V V V V V V V V V V V V V




ntration. This means that the:
V V V V




A. Concentration will produce therapeutic effects V V V V




B. Concentration will produce an adverse response V V V V V




C. Time between doses must be shortened
V V V V V




D. Duration of action of the drug is too long V V V V V V V V




ANS: B V PTS: 1 V




10. Drugs that are receptor agonists may demonstrate what property?
V V V V V V V V




A. Irreversible binding to the drug receptor site V V V V V V




B. Up-regulation with chronic use V V V




C. Desensitization or down-regulation with continuous use V V V V V




D. Inverse relationship between drug concentration and drug action
V V V V V V V




ANS: C V PTS: 1 V




11. Drugs that are receptor antagonists, such as beta blockers, may cause:
V V V V V V V V V V




A. Down-regulation of the drug receptor V V V V




B. An exaggerated response if abruptly discontinued
V V V V V




C. Partial blockade of the effects of agonist drugs
V V V V V V V




D. An exaggerated response to competitive drug agonists
V V V V V V




ANS: B V PTS: 1 V




12. Factors that affect gastric drug absorption include:
V V V V V V




A. Liver enzyme activity V V




B. Protein-binding properties of the drug molecule V V V V V




C. Lipid solubility of the drug V V V V




D. Ability to chew and swallow V V V V




ANS: C V PTS: 1 V